Beta-Hydroxybutyrate LiquiColor for diabetic ketoacidosis (DKA)
20 Feb 2025
Explore EKF Diagnostics' Beta-Hydroxybutyrate LiquiColor® reagent set, designed for in vitro use. This easy-to-use, fast, and quantitative test enables early detection and monitoring of ketosis. FDA-cleared for diagnostic accuracy, it allows clinicians to make swift, informed decisions, ensuring patients receive the necessary care they need in cases of diabetic ketoacidosis (DKA).
About the company
EKF Diagnostics
Empowering decision-making in point-of-care testing and life sciences applications.
EKF Diagnostics is a leading global diagnostics and biotechnology company specializing in the development, production, and distribution of innovative medical technologies and patient-centric solutions
We are committed to delivering high-quality, reliable, cost-effective tools that enable early detection, accurate diagnosis, therapeutic development, and effective condition monitoring.
Our products are designed to be cost-effective, providing accessible solutions to healthcare providers in diverse clinical settings, including hospitals, clinics, and laboratories.
EKF plays a critical role in the healthcare industry by offering high-quality, value-based diagnostic products. Our point-of-care testing devices allow healthcare professionals to perform rapid tests at the patient’s side, reducing the need for extensive lab testing and delivering quicker results. In addition, EKF is at the forefront of the life sciences sector, providing advanced tools that contribute to biotech development, research, and precision medicine.
Related products
Request Quote for All Products
Beta-Hydroxybutyrate LiquiColor®: Quantitative and quick test for ketosis
EKF DiagnosticsThe Stanbio Chemistry LiquiColor® Beta-Hydroxybutyrate (B-HB) reagent is a vital tool for detecting ketones and monitoring patient resolution in cases of diabetic ketoacidosis (DKA).
